GENEVA, 15 July 2025–Lenacapavir–a long-acting, six-monthly injectable antiretroviral medicine manufactured by Gilead Sciences–is now recommended by the World Health Organization as an additional HIV ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

Health leaders at the International AIDS Society (IAS) 2025 conference in Kigali have warned that shrinking funding and ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of the EXPrESSIVE Phase 3 ...

Until recently, the UN was on track to meet its target of ending AIDS as a public health threat by 2030. But with the U.S.

SA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year ...

Up to six million new HIV infections and four million AIDS-related deaths could occur between 2025 and 2029 if vital ...

The Joint United Nations Programme on HIV/AIDS (UNAIDS) has warned that decades of progress in addressing AIDS are at risk ...

Ghana recorded 15,290 new HIV infections with 12,614 AIDS related deaths in 2024, according to data from the National and Sub ...

The UNAIDS annual report warns that Trump-era HIV funding cuts could lead to 6 million more infections and 4 million deaths ...

The $4 billion that the United States pledged for the global HIV response for 2025 disappeared virtually overnight in January ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE ...